Safety fears as scientists make first viruses designed by AI

by | Aug 10, 2026 | Science

Safety fears as scientists make first viruses designed by AI

Researchers at Stanford University have successfully designed and created bacteriophage viruses—microorganisms that infect bacteria—using artificial intelligence genome models, marking a significant development in synthetic biology. The AI systems, trained on genetic data from millions of bacteriophages, generated thousands of potential viral designs, of which researchers selected and synthesized nearly 300 in the laboratory. When tested against resistant strains of E. coli bacteria, a combination of the AI-designed viruses proved effective at overcoming bacterial resistance.

The achievement demonstrates potential applications in treating persistent bacterial infections through phage therapy, allowing researchers to rapidly engineer viruses tailored to combat specific pathogens and resistance mechanisms. The findings, published in Science, suggest the technology could substantially advance biotechnological capabilities and expand treatment options for antibiotic-resistant infections.

However, the research has prompted significant warnings from the scientific and security communities regarding biosafety and biosecurity implications. Experts at Johns Hopkins University’s Center for Health Security noted that while the application holds promise for beneficial uses, the governance structures necessary to safely manage such technology remain underdeveloped. They emphasized that the ability to generate viral genomes using generative AI now exists, but corresponding regulatory frameworks have not kept pace.

Researchers deliberately limited the AI training data to exclude genetic information from viruses capable of infecting humans, animals, or plants to mitigate risks. Scientists and policymakers have called for multiple protective layers, including oversight of model development and data access, responsible research review processes, screening of synthesized genetic material, and established laboratory safety protocols. Experts acknowledge the technical challenges involved in designing more complex viral genomes, but stress the importance of preventing potential misuse while the technology remains in early stages of development.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI